Wilson Sonsini Goodrich & Rosati advised LENZ Therapeutics on the transaction.LENZ Therapeutics (Nasdaq: LENZ), a late clinical-stage biopharmaceutical company, announced that it has entered into a…
LENZ Therapeutics’ $30 Million Private Placement Financing
![](https://globallegalchronicle.com/wp-content/uploads/2024/07/lenz-therapeutics-30-million-private-placement-financing_669844d074f3f.jpeg)